TLDR Some drugs may reduce prostatitis symptoms short-term with few side effects.
The study assessed the effects of various pharmacological therapies for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in 9119 men across 99 studies. It found low- to very low-quality evidence that alpha blockers, antibiotics, 5-alpha reductase inhibitors, anti-inflammatories, phytotherapy, intraprostatic botulinum toxin A injection, and traditional Chinese medicine may reduce prostatitis symptoms without increasing adverse events in the short term, except for alpha blockers which may cause mild adverse events. There was limited evidence on the impact of these treatments on sexual dysfunction, quality of life, or anxiety and depression. Future trials should improve methodological reporting and include comprehensive assessments of patient-important outcomes and adverse events.
54 citations,
October 2019 in “Cochrane library” Some drugs may reduce prostatitis symptoms short-term with few side effects.
127 citations,
May 2004 in “PubMed” Finasteride may help some male chronic pelvic pain patients, but more research needed.
105 citations,
January 2004 in “The Journal of Urology” Finasteride improves chronic pelvic pain, saw palmetto doesn't.
65 citations,
March 1999 in “Urology” Finasteride didn't significantly improve ICPPS symptoms, more research needed.
20 citations,
December 2016 in “American Journal of Clinical Dermatology” Men prefer less invasive cosmetic procedures and need different treatment approaches than women.
19 citations,
November 2011 Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.
June 2024 in “Dermatology and therapy” Intramuscular injections improved hair density more than intradermal injections for treating hair loss.
May 2023 in “Clinical, Cosmetic and Investigational Dermatology” More personalized and effective treatments for androgenetic alopecia are needed.
June 2023 in “Drugs & Therapy Perspectives” New treatments for male pattern hair loss look promising, but established treatments are still the main option.
